홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

2-Methylbenzylamine → 4-amino-5-cyano-6-ethoxy-N-(2-methylbenzyl)pyridine-2-carboxamide

HRID 1364539
인쇄

반응식

HRID 1364539 반응식
[NH2:1][C:2]1[C:7]([C:8]#[N:9])=[C:6]([O:10][CH2:11][CH3:12])[N:5]=[C:4]([C:13]([OH:15])=O)[CH:3]=1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.[CH3:38][C:39]1[CH:46]=[CH:45][CH:44]=[CH:43][C:40]=1[CH2:41][NH2:42]>CC(N(C)C)=O>[NH2:1][C:2]1[C:7]([C:8]#[N:9])=[C:6]([O:10][CH2:11][CH3:12])[N:5]=[C:4]([C:13]([NH:42][CH2:41][C:40]2[CH:43]=[CH:44][CH:45]=[CH:46][C:39]=2[CH3:38])=[O:15])[CH:3]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 69932-MethylbenzylamineHCID 2733207O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborateHCID 118464604-Amino-5-cyano-6-ethoxypicolinic acid

생성물 1

HCID 669206414-amino-5-cyano-6-ethoxy-N-(2-methylbenzyl)pyridine-2-carboxamide

시약·촉매·용매 1

HCID 31374Dimethylacetamide용매4회

실험 절차

In a 20 mL scintillation vial, 4-amino-5-cyano-6-ethoxy-pyridine-2-carboxylic acid (19 mg, 0.09 mmol) was dissolved in DMA (0.7 mL). Then TBTU (30 mg, 0.09 mmol) dissolved in DMA (0.7 mL) was added, followed by the addition of 2-methylbenzylamine (12 mg, 0.11 mmol, 1.2 eq.) in DMA (0.6 mL). Then TEA (9.37 mg, 0.09 mmol) dissolved in DMA (0.7 mL) was added. The reaction mixture was shaken at room temperature for 24 hours. The crude mixture was purified using reverse phase HPLC (TFA). 1H NMR (500 MHz, DMSO-D6/D2O) δ ppm 1.31 (t, 3H) 2.28-2.34 (m, 3H) 4.38-4.55 (m, 4H) 7.05-7.10 (m, 1H) 7.11-7.21 (m, 4H) 8.92-8.99 (m, 1H). MS (ESI) positive ion 311 (M+H)+; negative ion 309 (M−H)−.

후처리

  1. additionwas added
  2. additionwas added
  3. customThe crude mixture was purified

출처 및 근거

ORD 기록
ord-b798384fcc9444e6ab912c5b0067d38b
출처 데이터셋
uspto-grants-2011_02
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07888374B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트